DagdemirA, DurifJ, NgolloM, BignonYJ, and Bernard-GallonD. (2013). Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Epigenomics, 5, 51–63.
2.
JudesG, DagdemirA, Karsli-CeppiogluS, et al. (2016). H3K4 acetylation, H3K9 acetylation, and H3K27 methylation in breast tumor molecular subtypes. Epigenomics, 8, in press.
3.
LehmannBD, BauerJA, ChenX, et al. (2011). Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest, 121, 2750–2767.
4.
NgolloM, LebertA, DagdemirA, et al. (2014). The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: Relationship with clinicopathological parameters. BMC Cancer, 14, 994.
5.
PetersKM, EdwardsSL, NairSS, et al. (2012). Androgen receptor expression predicts breast cancer survival: The role of genetic and epigenetic events. BMC Cancer, 12, 132.
